Category: Pharmaceutical Manufacturing
-
13 Jul
-
2 Jul
Manufacturing Transparency: How to Access FDA Inspection Records
Explore how FDA inspection records shape manufacturing transparency. Learn about access rights, Form 483 responses, and new 2025 regulations affecting pharmaceutical and device compliance. -
25 May
FDA Regulatory Authority: The Agency's Role in Generic Drug Approval
Explore the FDA's role in generic drug approval via the ANDA pathway. Learn about Hatch-Waxman, bioequivalence testing, and how generics save billions while ensuring safety. -
18 May
Authorized Generics Market Outlook: Strategy, Trends & Future Role (2026)
Explore the future role of authorized generics in the pharmaceutical market. We analyze strategic timing, regulatory shifts like the FDA's 2025 pilot program, and the impact on drug pricing and competition. -
27 Apr
Authorized Generics vs First-to-File Generics: Which is Cheaper?
Compare the costs of authorized generics versus first-to-file generics. Learn how market competition and FDA exclusivity impact your prescription prices. -
15 Apr
FDA GMP Requirements for Generic Drug Manufacturing: A Compliance Guide
Learn the essential FDA CGMP requirements for manufacturing generic drugs. This guide covers 21 CFR Part 211, data integrity, and how to avoid common compliance pitfalls.
- Recent
- Popular
